Company: HCWB
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0000950170-25-046724
Chunk: 126

Company: HCW Biologics Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 16
Chunk 126
---
None.

137  

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

    HCW Biologics Inc.

    Date: March 28, 2025
     
    By:
    /s/ Hing C. Wong, Ph.D.

    Hing C. Wong, Ph.D.

    Founder and Chief Executive Officer 

POWER OF ATTORNEY

Each person whose signature appears below constitutes and appoints Hing C. Wong and Rebecca Byam, and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes, may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

    Name
     
    Title
     
    Date

    /s/ Hing C. Wong, Ph.D.
     
    Founder, Chief Executive Officer 
     
     March 28, 2025

    Hing C. Wong, Ph.D.
     
     (Principal Executive Officer)

    /s/ Rebecca Byam
     
     Chief Financial Officer
     
     March 28, 2025

    Rebecca Byam
     
     (Principal Financial and Accounting Officer)

    /s/ Scott T. Garrett 
     
     Chairperson of the Board of Directors 
     
     March 28, 2025

    Scott T. Garrett  

    /s/ Lisa